Skip to content

Clinical trials

Rhabdomyosarcoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rhabdomyosarcoma Country / region: Germany Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20031
20041
20081
20091
20131
20151
20181
20191
20201
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC7
Eli Lilly and Company2
Novartis Pharmaceuticals2
University Hospital Tuebingen2
Boehringer Ingelheim1
Bristol-Myers Squibb1
Eisai Inc.1
Pfizer1
University Hospital, Basel, Switzerland1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rhabdomyosarcoma18
Sarcoma11
Sarcoma, Synovial10
Leiomyosarcoma8
Fibrosarcoma7
Hemangiosarcoma7
Histiocytoma, Malignant Fibrous7
Liposarcoma7
Neurofibrosarcoma7
Neuroblastoma6

Trials

Showing 51 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.